467 related articles for article (PubMed ID: 30131239)
21. A randomized trial to compare procalcitonin and C-reactive protein in assessing severity of sepsis and in guiding antibacterial therapy in Egyptian critically ill patients.
Ali WA; Bazan NS; Elberry AA; Hussein RRS
Ir J Med Sci; 2021 Nov; 190(4):1487-1495. PubMed ID: 33447966
[TBL] [Abstract][Full Text] [Related]
22. Predictive role of selected biomarkers in differentiating gram-positive from gram-negative sepsis in surgical patients: a retrospective study.
Nešković N; Drenjančević D; Kvolik S; Škiljić S; Budrovac D; Drenjančević IH
Anaesthesiol Intensive Ther; 2023; 55(5):319-325. PubMed ID: 38282497
[TBL] [Abstract][Full Text] [Related]
23. MR- proADM to detect specific types of organ failure in infection.
Andrés C; Andaluz-Ojeda D; Cicuendez R; Nogales L; Martín S; Martin-Fernandez M; Almansa R; Calvo D; Esteban-Velasco MC; Vaquero-Roncero LM; Ríos-Llorente A; Sanchez-Barrado E; Muñoz-Bellvís L; Aldecoa C; Bermejo-Martin JF
Eur J Clin Invest; 2020 Jun; 50(6):e13246. PubMed ID: 32307701
[TBL] [Abstract][Full Text] [Related]
24. The value of sepsis biomarkers and their kinetics in the prognosis of septic shock due to bacterial infections.
Bahloul M; Bradii S; Turki M; Bouchaala K; Ben Hamida C; Chelly H; Ayedi F; Bouaziz M
Anaesthesiol Intensive Ther; 2021; 53(4):312-318. PubMed ID: 35257563
[TBL] [Abstract][Full Text] [Related]
25. Role of procalcitonin in predicting etiology in bacteremic patients: Report from a large single-center experience.
Bassetti M; Russo A; Righi E; Dolso E; Merelli M; D'Aurizio F; Sartor A; Curcio F
J Infect Public Health; 2020 Jan; 13(1):40-45. PubMed ID: 31248812
[TBL] [Abstract][Full Text] [Related]
26. Performance enhancement of procalcitonin by high-sensitivity C-reactive protein at the optimal cutoff in predicting bacteremia in emergency department adult patients.
Kok VC; Lin CT; Yeh CB; Yang CC; Horng JT
Scand J Clin Lab Invest; 2019; 79(1-2):25-31. PubMed ID: 30628465
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the clinical performance of an automated procalcitonin assay for the quantitative detection of bloodstream infection.
Kim KE; Han JY
Korean J Lab Med; 2010 Apr; 30(2):153-9. PubMed ID: 20445333
[TBL] [Abstract][Full Text] [Related]
28. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
[TBL] [Abstract][Full Text] [Related]
29. Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients.
Cabanillas Stanchi KM; Queudeville M; Malaval C; Feucht J; Schlegel P; Dobratz M; Seitz C; Müller I; Lang P; Handgretinger R; Döring M
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2779-2791. PubMed ID: 31446489
[TBL] [Abstract][Full Text] [Related]
30. [The diagnostic value of different pro-inflammatory factor in early diagnosis of sepsis in patients with bloodstream infection].
Chen W; Zhao L; Niu S; Wang S; Sheng B; Zhen J; Gu X; Lyu C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):165-70. PubMed ID: 24598289
[TBL] [Abstract][Full Text] [Related]
31. Clinical utility of procalcitonin as a marker of sepsis: a potential predictor of causative pathogens.
Nakajima A; Yazawa J; Sugiki D; Mizuguchi M; Sagara H; Fujisiro M; Shibazaki M; Hitani A; To M; Haruki K
Intern Med; 2014; 53(14):1497-503. PubMed ID: 25030560
[TBL] [Abstract][Full Text] [Related]
32. Procalcitonin is a marker of gram-negative bacteremia in patients with sepsis.
Guo SY; Zhou Y; Hu QF; Yao J; Wang H
Am J Med Sci; 2015 Jun; 349(6):499-504. PubMed ID: 25992537
[TBL] [Abstract][Full Text] [Related]
33. Research on the diagnostic effect of PCT level in serum on patients with sepsis due to different pathogenic causes.
Gai L; Tong Y; Yan BQ
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4238-4242. PubMed ID: 30024613
[TBL] [Abstract][Full Text] [Related]
34. Comparative diagnostic test evaluation of serum procalcitonin and C-reactive protein in suspected bloodstream infections in children with cancer.
R Nath S; Jayapalan S; Nair H; Kusumakumary P; Prema NS; Priyakumari T; Rajamohanan K
J Med Microbiol; 2017 May; 66(5):622-627. PubMed ID: 28504925
[TBL] [Abstract][Full Text] [Related]
35. Comparison of interleukin-6, interleukin-10, procalcitonin and C-reactive protein in identifying high-risk febrile illness in pediatric cancer patients: A prospective observational study.
Xu XJ; Luo ZB; Xia T; Song H; Yang SL; Xu WQ; Ni YR; Ning Zhao ; Tang YM
Cytokine; 2019 Apr; 116():1-6. PubMed ID: 30684912
[TBL] [Abstract][Full Text] [Related]
36. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis.
Castelli GP; Pognani C; Cita M; Stuani A; Sgarbi L; Paladini R
Minerva Anestesiol; 2006; 72(1-2):69-80. PubMed ID: 16407808
[TBL] [Abstract][Full Text] [Related]
37. Procalcitonin and C-reactive protein in differantiating to contamination from bacteremia.
Oksuz L; Somer A; Salman N; Erk O; Gurler N
Braz J Microbiol; 2014; 45(4):1415-21. PubMed ID: 25763049
[TBL] [Abstract][Full Text] [Related]
38. The Diagnostic Value of Procalcitonin Versus Other Biomarkers in Prediction of Bloodstream Infection.
Pan YP; Fang YP; Xu YH; Wang ZX; Shen JL
Clin Lab; 2017 Feb; 63(2):277-285. PubMed ID: 28182347
[TBL] [Abstract][Full Text] [Related]
39. Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis.
Dahaba AA; Hagara B; Fall A; Rehak PH; List WF; Metzler H
Br J Anaesth; 2006 Oct; 97(4):503-8. PubMed ID: 16849384
[TBL] [Abstract][Full Text] [Related]
40. Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED.
Zhou H; Guo S; Lan T; Ma S; Zhang F; Zhao Z
Am J Emerg Med; 2018 Dec; 36(12):2155-2160. PubMed ID: 29691103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
